- Home
- CMAX vs BMRA Comparison
CMAX vs BMRA Comparison
Compare CMAX & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMAX
- BMRA
- Stock Information
- Founded
- CMAX 2011
- BMRA 1971
- Country
- CMAX United States
- BMRA United States
- Employees
- CMAX N/A
- BMRA N/A
- Industry
- CMAX Computer Software: Prepackaged Software
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CMAX Technology
- BMRA Health Care
- Exchange
- CMAX Nasdaq
- BMRA Nasdaq
- Market Cap
- CMAX 7.6M
- BMRA 7.4M
- IPO Year
- CMAX N/A
- BMRA N/A
- Fundamental
- Price
- CMAX $1.85
- BMRA $0.33
- Analyst Decision
- CMAX Hold
- BMRA
- Analyst Count
- CMAX 2
- BMRA 0
- Target Price
- CMAX $33.20
- BMRA N/A
- AVG Volume (30 Days)
- CMAX 58.0K
- BMRA 68.2K
- Earning Date
- CMAX 11-07-2024
- BMRA 10-15-2024
- Dividend Yield
- CMAX N/A
- BMRA N/A
- EPS Growth
- CMAX N/A
- BMRA N/A
- EPS
- CMAX N/A
- BMRA N/A
- Revenue
- CMAX $784,551,000.00
- BMRA $5,509,000.00
- Revenue This Year
- CMAX $13.01
- BMRA N/A
- Revenue Next Year
- CMAX $32.42
- BMRA N/A
- P/E Ratio
- CMAX N/A
- BMRA N/A
- Revenue Growth
- CMAX 9.06
- BMRA 1.74
- 52 Week Low
- CMAX $1.55
- BMRA $0.24
- 52 Week High
- CMAX $74.70
- BMRA $2.13
- Technical
- Relative Strength Index (RSI)
- CMAX 46.01
- BMRA 47.85
- Support Level
- CMAX $1.60
- BMRA $0.28
- Resistance Level
- CMAX $2.39
- BMRA $0.35
- Average True Range (ATR)
- CMAX 0.19
- BMRA 0.04
- MACD
- CMAX 0.07
- BMRA 0.00
- Stochastic Oscillator
- CMAX 32.50
- BMRA 41.67
About CMAX CareMax Inc.
CareMax Inc is a technology-enabled care platform providing value-based care and chronic disease management to seniors. It operates various owned medical centers that offer a comprehensive suite of healthcare and social services and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.